Apontis Pharma AG Logo

Apontis Pharma AG

ISIN

DE000A3CMGM5

Ticker

APPH

Sector

Health Care

Sub-Industry

Biotechnology

Country

Germany

Year Founded

1946

About Apontis Pharma AG

Company Description

APONTIS PHARMA AG is a leading pharmaceutical company in Germany that specialises in single pills. Single Pills combine two to three generic active ingredients in one combination preparation. APONTIS PHARMA develops, markets and distributes a broad portfolio of Single Pills and other medicines, with a particular focus on cardiovascular diseases. Since 2013, APONTIS has successfully launched several Single Pills solely for cardiovascular indications such as hypertension, hyperlipidaemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in the heart of Europe's strongest pharmaceutical and chemical region. From here, the company maintains a broad network with research-based pharmaceutical companies and a target customer group of around 23,000 doctors in Germany.

Headcount

168

Served Area

Germany

Headquarters

Alfred-Nobel-Str. 10
40789, Monheim
Germany

Filings & Publications

  • Consolidated Report 2022 - Q2 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q2 English πŸ‡¬πŸ‡§
  • Company Presentation 2022 - Q3 English πŸ‡¬πŸ‡§
  • Consolidated Report 2022 - Q4 English πŸ‡¬πŸ‡§
  • Consolidated Report 2021 - Q4 German πŸ‡©πŸ‡ͺ
  • Consolidated Report 2021 - Q4 English πŸ‡¬πŸ‡§

Insider Trades

Date Trading entity / Person Association Trade type Volume
14.05.2024 Milz, Thomas Board Buy EUR 8,960.00
14.05.2024 be executive GmbH Close relation Buy EUR 8,880.00
13.05.2024 Zimmermann, Thomas Other Buy EUR 10,128.00
13.05.2024 Zimmermann, Thomas Other Buy EUR 3,396.00
13.05.2024 Zimmermann, Thomas Other Buy EUR 1,692.00
13.05.2024 Zimmermann, Thomas Other Buy EUR 1,688.00
05.05.2023 Reineke, Silke Close relation Buy EUR 36,625.00
05.05.2023 Milz, Thomas Board Buy EUR 14,360.00

Capital Markets Information

ISIN

DE000A3CMGM5

LEI

894500ETO1J6MR8PDF91

Sub-Industry

Biotechnology

Designated Sponsor

Hauck AufhΓ€user Lampe Privatbank AG

Listed Stock Exchange

Frankfurt Stock Exchange

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.